Thermo Fisher Scientific Stock News

Strength in end markets and significant contribution from COVID-response related revenues are driving Thermo Fisher's (TMO) top line.

WALTHAM, Mass. , Dec. 30, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N.

The NASDAQ is likely to be the leading index through the first week of January.

Princeton Global Asset Management LLC lowered its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 40.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,666 shares of the medical research companys stock after selling 3,817 shares during the quarter. []

The western blotting market has seen a substantial number of new product introductions by major companies in recent years. These items were created to improve the accuracy and efficiency of western blotting while also reducing the processing time. Due to the

In the near future, expansion in the worldwide pharmaceutical industry is most expected to drive the global trypsin market. Furthermore, during the projection period, the minimal risk of viruses and other harmful agents in the trypsin solution is likely to

In the approaching years, the separation system market for commercial biotechnology is expected to expand. The market''s expansion may be ascribed to a number of factors, including government funding in some countries, technological breakthroughs in the sector, the implementation of

Thermo Fisher's (TMO) TaqMan SARS-CoV-2 Mutation Panel currently offers direct identification of the novel variant of concern.

The virology specimen collection market is divided into blood, nasopharyngeal, nasal, throat, cervical, oral and different examples. The blood fragment represented the most elevated development rate. Factors, for example, the rising number of blood gifts and rising commonness of viral

Related Stocks: ARGX , MGNX , CUTR , RNA , FULC , ITOS , TMO , PEN , TNYA , SGHT , AADI , RCOR , PTGX , MDXG , CSTL , AGEN , ABUS , QDEL , TRIL , CHAQ , BCTG , ITMR , RACA ,

DUBLIN--(BUSINESS WIRE)--The "Dengue Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021-2026)" report has been added to ResearchAndMarkets.com''s offering. The global dengue testing market was valued at USD 455.77 million in 2020 and is expected to reach USD 597.78 million by 2026, registering a CAGR of 4.74% during the forecast period. Dengue viruses and the virus that causes COVID-19 virus cause similar symptoms in the early stages. So, most of the people are confusing it to

Los Angeles, United State: The report is a compilation of comprehensive research studies on various aspects of the global Scaffold Free 3D Cell Culture Plate Market. With accurate data and highly authentic information, it makes a brilliant attempt to provide

Los Angeles, United State: The report is a compilation of comprehensive research studies on various aspects of the global 3D Cell Culture Scaffold Market. With accurate data and highly authentic information, it makes a brilliant attempt to provide a real,

Royal London Asset Management Ltd. increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 754,845 shares of the medical research companys stock after acquiring an additional 3,552 shares during the []